Remdesivir (Veklury) for COVID-19
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
The Medical letter on drugs and therapeutics - 62(2020), 1612 vom: 30. Nov., Seite 186-188 |
| Sprache: |
Englisch |
|---|
| Anmerkungen: |
Date Completed 21.01.2021 Date Revised 07.12.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM320067599 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320067599 | ||
| 003 | DE-627 | ||
| 005 | 20231225172803.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1066.xml |
| 035 | |a (DE-627)NLM320067599 | ||
| 035 | |a (NLM)33443491 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Remdesivir (Veklury) for COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.01.2021 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Veklury | |
| 650 | 4 | |a adverse effects | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a dosage | |
| 650 | 4 | |a drug interactions | |
| 650 | 4 | |a efficacy | |
| 650 | 4 | |a hydroxychloroquine | |
| 650 | 4 | |a interferon beta | |
| 650 | 4 | |a lactation | |
| 650 | 4 | |a lopinavir/ritonavir | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a remdesivir | |
| 650 | 4 | |a safety | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a remdesivir |2 NLM | |
| 650 | 7 | |a 3QKI37EEHE |2 NLM | |
| 650 | 7 | |a Adenosine Monophosphate |2 NLM | |
| 650 | 7 | |a 415SHH325A |2 NLM | |
| 650 | 7 | |a Alanine |2 NLM | |
| 650 | 7 | |a OF5P57N2ZX |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t The Medical letter on drugs and therapeutics |d 1965 |g 62(2020), 1612 vom: 30. Nov., Seite 186-188 |w (DE-627)NLM000074810 |x 1523-2859 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2020 |g number:1612 |g day:30 |g month:11 |g pages:186-188 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2020 |e 1612 |b 30 |c 11 |h 186-188 | ||